Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
Schlenk RF, Fröhling S, Hartmann F, Fischer JT, Glasmacher A, del Valle F, Grimminger W, Götze K, Waterhouse C, Schoch R, Pralle H, Mergenthaler HG, Hensel M, Koller E, Kirchen H, Preiss J, Salwender H, Biedermann HG, Kremers S, Griesinger F, Benner A, Addamo B, Döhner K, Haas R, Döhner H; AML Study Group Ulm.
Schlenk RF, et al. Among authors: salwender h.
Leukemia. 2004 Nov;18(11):1798-803. doi: 10.1038/sj.leu.2403528.
Leukemia. 2004.
PMID: 15385923
Clinical Trial.